[Federal Register Volume 60, Number 36 (Thursday, February 23, 1995)]
[Notices]
[Page 10090]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-4335]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Ad Hoc Review Committee for the Recombinant DNA Advisory
Committee; Notice of Meeting
Notice is hereby given of a meeting of the Ad Hoc Review Committee
for the Recombinant DNA Advisory Committee on March 8, 1995, at the
National Institutes of Health, Building 31C, 6th Floor, Conference Room
8, 9000 Rockville Pike, Bethesda, Maryland 20892, starting at
approximately 9 a.m. to adjournment at approximately 5 p.m. The meeting
will be open to the public to discuss three major topics for review:
(1) domain and mandate of the Recombinant DNA Advisory Committee; (2)
composition of the Recombinant DNA Advisory Committee; and (3)
Recombinant DNA Advisory Committee's review of human gene transfer
protocols. Members of the public wishing to speak at this meeting may
be given such opportunity at the discretion of the Chair.
Dr. Nelson A. Wivel, Director, Office of Recombinant DNA
Activities, Suite 323, National Institutes of Health, 6006 Executive
Boulevard, MSC 7052, Bethesda, Maryland 20892-7052, Phone (301) 496-
9838, FAX (301) 496-9839, will provide materials to be discussed at
this meeting, roster of committee members, and substantive program
information. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should contact Dr. Wivel in advance of the meeting. A
summary of the meeting will be available at a later date.
OMB's ``Mandatory Information Requirements for Federal Assistance
Program Announcements'' (45 FR 39592, June 11, 1980) requires a
statement concerning the official government programs contained in the
Catalog of Federal Domestic Assistance. Normally NIH lists in its
announcements the number and title of affected individual programs for
the guidance of the public. Because the guidance in this notice covers
not only virtually every NIH program but also essentially every Federal
research program in which DNA recombinant molecule techniques could be
used, it has been determined not to be cost effective or in the public
interest to attempt to list these programs. Such a list would likely
require several additional pages. In addition, NIH could not be certain
that every Federal program would be included as many Federal agencies,
as well as private organizations, both national and international, have
elected to follow the NIH Guidelines. In lieu of the individual program
listing, NIH invites readers to direct questions to the information
address above about whether individual programs listed in the Catalog
of Federal Domestic Assistance are affected.
Dated: February 15, 1995.
Susan K. Feldman,
Committee Management Officer, NIH.
FR Doc. 95-4335 Filed 2-22-95; 8:45 am]
BILLING CODE 4140-01-M
